Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ketamine Effects on Learning In Eating Disorders
Sponsor: Amanda Downey, MD
Summary
This is a single site, single dose clinical trial of intravenous (IV) ketamine for medically hospitalized adolescents and young adults with anorexia nervosa or atypical anorexia nervosa. Eating disorder symptoms will be measured pre- and post-ketamine infusion. Investigators hypothesize that ketamine will increase cognitive flexibility, making medical hospitalizations less distressing by improving the ability to learn new, positive associations with food.
Official title: "KETTLE" Trial: Ketamine Effects on Learning In Eating Disorders
Key Details
Gender
All
Age Range
16 Years - 26 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-06-05
Completion Date
2026-06
Last Updated
2025-06-10
Healthy Volunteers
No
Interventions
Ketamine infusion
Ketamine will be delivered intravenously at 0.5 mg/kg over 40 minutes.
Locations (1)
University of California, San Francisco
San Francisco, California, United States